# SCRT1

## Overview
SCRT1, or scratch family transcriptional repressor 1, is a gene that encodes a zinc-finger transcription factor belonging to the Snail superfamily. This protein is characterized by its SNAG domain and multiple C2H2-type zinc finger motifs, which are essential for its role as a transcriptional repressor (Marín2006The; Puisieux2009The). SCRT1 is primarily involved in the regulation of insulin secretion and beta cell function, playing a critical role in glucose-stimulated insulin secretion (GSIS) in pancreatic beta cells (Chriett2021SCRT1). The protein's activity is modulated by post-translational modifications, such as phosphorylation, which affect its cellular localization and stability (Chriett2021SCRT1). SCRT1's interactions with other proteins, including GSK3β and FBXO11, further underscore its regulatory functions in cellular processes (Jin2015FBXO11). Alterations in SCRT1 expression have been linked to the pathophysiology of type 2 diabetes, highlighting its clinical significance in metabolic disorders (Chriett2021SCRT1).

## Structure
SCRT1, a member of the Snail superfamily of zinc-finger transcription factors, is characterized by a conserved SNAG domain at the N-terminus and multiple C2H2-type zinc finger motifs, which facilitate DNA binding and transcriptional repression (Marín2006The; Puisieux2009The). The protein's structure includes a SNAG transactivation domain and five zinc fingers, along with a characteristic Scratch domain, typical features of the Snail superfamily (Marín2006The). 

SCRT1 undergoes post-translational modifications such as phosphorylation, which can influence its activity and stability. Specifically, GSK3β-mediated serine phosphorylation regulates the translocation of SCRT1 from the nucleus to the cytosol, a process influenced by glucose levels and associated with insulin secretion in beta cells (Chriett2021SCRT1). 

Alternative splicing of the SCRT1 gene can result in different isoforms, potentially affecting its function and interactions, although specific details on these isoforms are not provided in the context (Benoit2015Transcriptomics). The molecular structure of SCRT1, including its specific tertiary and quaternary structures, is not detailed in the available sources.

## Function
SCRT1 is a transcription factor that plays a crucial role in the regulation of insulin secretion and beta cell function in healthy human cells. It is expressed specifically in beta cells within human and mouse islets, where it is involved in glucose-stimulated insulin secretion (GSIS) (Chriett2021SCRT1). SCRT1 directly binds to E-box motifs in the promoters of insulin genes, such as Ins1 and Ins2, to regulate their expression. This binding is essential for maintaining normal insulin transcription and secretion (Chriett2021SCRT1).

SCRT1's expression is positively correlated with key beta cell genes, including INS, MAFA, PDX1, ISL1, and NEUROD1, which are important for beta cell function. It also interacts with GSK3β, and its nuclear localization is influenced by serine phosphorylation, which can lead to its translocation to the cytosol and subsequent degradation (Chriett2021SCRT1). In healthy cells, SCRT1 promotes insulin secretion and maintains beta cell viability by reducing apoptosis (Chriett2021SCRT1).

SCRT1 is also involved in the regulation of beta cell proliferation and maturation. It acts as a transcriptional repressor, influencing the expression of genes related to proliferation and glucose signaling, which are crucial for the development and function of beta cells (Sobel2021Scrt1).

## Clinical Significance
Mutations and alterations in the expression of the SCRT1 gene have been implicated in the pathophysiology of type 2 diabetes (T2D). SCRT1 is a transcription factor that plays a crucial role in regulating insulin secretion in pancreatic beta cells. In T2D, SCRT1 expression is reduced in beta cells, which correlates with impaired glucose-stimulated insulin secretion and decreased expression of key insulin-related genes such as INS, MAFA, and PDX1 (Chriett2021SCRT1). This reduction in SCRT1 expression is associated with its translocation from the nucleus to the cytosol under diabetic conditions, suggesting a disruption in its normal regulatory functions (Chriett2021SCRT1).

The gene's expression is also modulated by glucose levels and GSK3β-mediated phosphorylation, with high glucose levels suppressing SCRT1 expression, potentially exacerbating hyperglycemia in diabetic patients (Chriett2021SCRT1). While large-scale genome-wide association studies (GWAS) have not reported common variants of SCRT1 associated with T2D risk, rare deleterious variants may influence insulin secretion and beta cell function, indicating a potential role in diabetes pathogenesis (Chriett2021SCRT1). Understanding these alterations in SCRT1 could provide insights into therapeutic strategies for diabetes management.

## Interactions
SCRT1 (scratch family transcriptional repressor 1) is involved in several protein-protein interactions that are crucial for its function as a transcriptional regulator. It interacts with GSK3β, a kinase that potentially regulates SCRT1's translocation from the nucleus to the cytosol through serine phosphorylation. This interaction suggests a regulatory mechanism involving phosphorylation, as demonstrated by protein complex immunoprecipitation (Chriett2021SCRT1).

SCRT1 is also targeted by FBXO11, a ubiquitin ligase that promotes the degradation and polyubiquitination of SCRT1, leading to its accelerated protein turnover. This process is dependent on the F-box domain of FBXO11, which recruits the ubiquitin-conjugating enzyme, highlighting a role in protein stability regulation (Jin2015FBXO11).

Additionally, SCRT1 interacts with LSD1, a chromatin-modifying enzyme, via its SNAG domain. This interaction is significant for the functioning of LSD1 and its cofactors, affecting transcriptional repression and various biological outcomes (Gu2020Biological).

These interactions underscore SCRT1's role in modulating gene expression and its involvement in complex regulatory networks within cells.


## References


[1. (Jin2015FBXO11) Yue Jin, Anitha K. Shenoy, Samuel Doernberg, Hao Chen, Huacheng Luo, Huangxuan Shen, Tong Lin, Miriam Tarrash, Qingsong Cai, Xin Hu, Ryan Fiske, Ting Chen, Lizi Wu, Kamal A. Mohammed, Veerle Rottiers, Siu Sylvia Lee, and Jianrong Lu. Fbxo11 promotes ubiquitination of the snail family of transcription factors in cancer progression and epidermal development. Cancer Letters, 362(1):70–82, June 2015. URL: http://dx.doi.org/10.1016/j.canlet.2015.03.037, doi:10.1016/j.canlet.2015.03.037. This article has 65 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.canlet.2015.03.037)

[2. (Sobel2021Scrt1) Jonathan Sobel, Claudiane Guay, Ofer Elhanani, Adriana Rodriguez-Trejo, Lisa Stoll, Véronique Menoud, Cécile Jacovetti, Michael D. Walker, and Romano Regazzi. Scrt1, a transcriptional regulator of β-cell proliferation identified by differential chromatin accessibility during islet maturation. Scientific Reports, April 2021. URL: http://dx.doi.org/10.1038/s41598-021-88003-2, doi:10.1038/s41598-021-88003-2. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-021-88003-2)

[3. (Chriett2021SCRT1) S. Chriett, A. Lindqvist, L. Shcherbina, A. Edlund, M. Abels, O. Asplund, J.A. Martínez López, E. Ottosson-Laakso, G. Hatem, R.B. Prasad, L. Groop, L. Eliasson, O. Hansson, and N. Wierup. Scrt1 is a novel beta cell transcription factor with insulin regulatory properties. Molecular and Cellular Endocrinology, 521:111107, February 2021. URL: http://dx.doi.org/10.1016/j.mce.2020.111107, doi:10.1016/j.mce.2020.111107. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.mce.2020.111107)

[4. (Gu2020Biological) Feiying Gu, Yuxin Lin, Zhun Wang, Xiaoxin Wu, Zhenyue Ye, Yuezhen Wang, and Huiyin Lan. Biological roles of lsd1 beyond its demethylase activity. Cellular and Molecular Life Sciences, 77(17):3341–3350, March 2020. URL: http://dx.doi.org/10.1007/s00018-020-03489-9, doi:10.1007/s00018-020-03489-9. This article has 68 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-020-03489-9)

[5. (Benoit2015Transcriptomics) Jamie Benoit, Albert E. Ayoub, and Pasko Rakic. Transcriptomics of critical period of visual cortical plasticity in mice. Proceedings of the National Academy of Sciences, 112(26):8094–8099, June 2015. URL: http://dx.doi.org/10.1073/pnas.1509323112, doi:10.1073/pnas.1509323112. This article has 28 citations.](https://doi.org/10.1073/pnas.1509323112)

[6. (Marín2006The) Faustino Marín and M. Angela Nieto. The expression of scratch genes in the developing and adult brain. Developmental Dynamics, 235(9):2586–2591, June 2006. URL: http://dx.doi.org/10.1002/dvdy.20869, doi:10.1002/dvdy.20869. This article has 39 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/dvdy.20869)

[7. (Puisieux2009The) Puisieux. The snail family member scratch1 is not expressed in human tumors. Oncology Reports, December 2009. URL: http://dx.doi.org/10.3892/OR_00000665, doi:10.3892/or_00000665. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/OR_00000665)